MetalloBio

Private

SheffieldHealthcare & Life Scienceshttps://www.metallobio.com/

Last Round

Early Funding

May 27, 2026

Est. Valuation

$5.07M

Total Funding Raised

$1.85M

Company Overview

MetalloBio is a biotechnology company developing novel antimicrobial platform technology to prevent and treat antimicrobial-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial resistanceAMRantimicrobial coatingsmetal-based antimicrobialssuperbug treatmentbiotechnologysurface protectionmedical device coatingsmetallodrugsdrug-resistant bacteriaadvanced materialsbacterial colonizationbiotech licensingantimicrobial additives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MetalloBio Comps

Public and private peers based on sector, stage, and business model.

MetalloBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MetalloBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	May 27, 2026
Crowdfunding	Dec 19, 2024
Grant	Aug 7, 2024
Grant	Sep 9, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Kirsty Smitten

CEO and co-founder

Founding Team

RTTP Dr Michael Murray

Chief Executive Officer

Executive Team

Richard A. Senior

Chief Operating Officer

Executive Team

MetalloBio Investors

Notable investors and investment history

MetalloBio investors
Investor	Rounds
Innovate UK	Grant
Medical Research Council	Grant
Oxford Technology	Early Funding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 2, 2025
Monthly visitors increased 1832% from 31 to 599.
Sep 9, 2021
$60K grant from Medical Research Council

View all signals

MetalloBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MetalloBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MetalloBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSheffield

Employee Range8

Year Founded2021

Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.